Cite
HARVARD Citation
Ott, P. et al. (n.d.). 1127OA personal neoantigen vaccine, NEO-PV-01, with anti-PD1 induces broad de novo anti-tumor immunity in patients with metastatic melanoma, NSCLC, and bladder cancer. Annals of oncology. p. . [Online].